LP
PNT

LMR Partners’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

LMR Partners’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-61,327
Closed -$343K – 1390
2021
Q4 		$343K Buy
+61,327
New +$460K ﹤0.01% 996

LMR Partners's PNT Position: Q1 2022 in Review

LMR Partners sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q1 2022, closing a stake of 61,327 shares — an estimated $343K sold.

LMR Partners first reported a position in PNT in Q4 2021 and held it in 1 quarter. The position peaked at $343K in Q4 2021. 68 funds tracked by Wall St. Rank hold PNT as of Q1 2022.

  • LMR Partners reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • LMR Partners sold 61,327 POINT Biopharma Global Inc. Common Stock shares in Q1 2022, an estimated $343K.
  • LMR Partners first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • LMR Partners's POINT Biopharma Global Inc. Common Stock position peaked at $343K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q1 2022.

Based on LMR Partners's 13F filing for Q1 2022, filed 16 May 2022.